Project maturity
The work is presented as an active research collaboration, not as a commercially available product.
Innovation
GBM combines scientific collaboration, intellectual property, development pathways and commercialization experience.
A C$300,000 Innovate BC Ignite award supports a collaboration among Geno10X, Gene Bio Medical and Simon Fraser University.
The project advances an AI-enhanced HPV point-of-care diagnostic platform integrating molecular detection, sensor science and risk prediction.
The work is presented as an active research collaboration, not as a commercially available product.
Accessible detection technologies and point-of-care pathways.
Data-informed risk prediction and decision support.
IP, validation, regulatory planning and pathways to commercialization.